Amarin Corp Plcuk (AMRN) Cash from Operations Growth (5y) (2015 - 2026)

Amarin Corp Plcuk (AMRN) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.55%
Dec 31, 2025 19.12%
Sep 30, 2025 -25.95%
Jun 30, 2025 59.93%
Mar 31, 2025 -38.04%
Dec 31, 2024 -8.29%
Sep 30, 2024 -16.09%
Jun 30, 2024 -16.79%
Mar 31, 2024 19.85%
Dec 31, 2023 54.28%
Sep 30, 2023 17.72%
Jun 30, 2023 18.07%
Mar 31, 2023 6.50%
Dec 31, 2022 22.20%
Sep 30, 2022 -23.74%
Jun 30, 2022 -43.80%
Mar 31, 2022 -48.01%
Dec 31, 2021 -7.90%
Sep 30, 2021 24.68%
Jun 30, 2021 -11.15%